New Parkinson's gel aims to smooth out daily symptoms
NCT ID NCT07313176
Summary
This study is observing how well a gel medication (LECIGON®) works over 12 months for people with advanced Parkinson's disease. It involves 215 adults who were previously treated with a different subcutaneous medication. The main goal is to see if the gel reduces daily 'off' periods when symptoms are worse and improves overall quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED PARKINSON DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Complejo Hospitalario Universitario de A Coruña (CHUAC)
RECRUITINGA Coruña, 15006, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Virgen del Rocío University Hospital
RECRUITINGSeville, Av. Manuel Siurot, S/n, 41013, Spain
Contact
Conditions
Explore the condition pages connected to this study.